This test is most useful if any of these apply to you.
If you have stubborn gut symptoms that flare with certain foods or feel different from a typical infection, a standard stool inflammation test may come back reassuringly normal. That can happen because the most commonly used fecal marker tracks one type of immune cell, and it can quietly miss a different, allergy-driven pattern of inflammation that another immune cell produces.
EPX (eosinophil protein X), also called eosinophil-derived neurotoxin, is a chemical released by an allergy-related white blood cell called the eosinophil. When eosinophils are active in your intestines, they spill EPX into your stool. Measuring it gives you a window into a specific kind of gut inflammation tied to food sensitivities, certain forms of inflammatory bowel disease, and allergic conditions.
Eosinophils are white blood cells that your body deploys against allergens, parasites, and certain forms of tissue injury. When they activate and rupture (a process called degranulation), they release their contents, including EPX, into the surrounding tissue. Finding EPX in your stool means eosinophils have been doing damage in your intestinal lining recently.
This is different from counting eosinophils in your blood. A blood eosinophil count tells you how many of these cells are circulating. Fecal EPX tells you what they are actually doing at the gut wall. The two numbers can disagree, which is why EPX adds information a complete blood count cannot provide on its own.
The strongest clinical use of fecal EPX is helping distinguish organic bowel disease from functional bowel symptoms. In adults with chronic diarrhea, a fecal EPX cutoff of 1,357 nanograms per milliliter correctly ruled out active inflammatory bowel disease (IBD, which includes Crohn's disease and ulcerative colitis) in roughly 89 out of 100 people who did not have active disease. The same cutoff caught only about 50 out of 100 people who did have active disease, so a normal result is less reassuring than a high result is informative.
When the test goes up, it tends to mean something. In that study, fecal EPX showed higher specificity and a higher positive predictive value for active IBD than fecal calprotectin, the more commonly used stool inflammation marker. In other words, a high fecal EPX was more likely to reflect real disease activity than a high calprotectin result in the same patients.
Fecal EPX also moves with treatment. In a cohort of IBD patients starting biologic therapy or corticosteroids, fecal EPX fell significantly in those who achieved clinical remission. That makes it useful not only for asking whether disease is active now, but also for asking whether a treatment is actually calming the gut.
In infants with atopic eczema and food allergy, fecal EPX is markedly elevated compared with healthy controls, reflecting allergic inflammation inside the gut even when symptoms are mostly on the skin. When an accurate elimination diet is started, fecal EPX drops, tracking the resolution of that intestinal inflammation. This pattern supports using fecal EPX to monitor whether an elimination diet is truly quieting the immune response in the gut, not just reducing the symptoms you notice.
In irritable bowel syndrome (IBS), a condition once assumed to involve no measurable inflammation, fecal EPX can be elevated even when calprotectin and neutrophil markers are not. One study in adults with IBS found higher fecal markers reflecting intestinal epithelial cell activity and eosinophil activity, without classic inflammatory signals. If you have been told your symptoms are functional but a low-level immune process keeps simmering, fecal EPX may detect activity that other tests miss.
Fecal EPX is an emerging marker without fully standardized clinical cutpoints. The ranges below come from published research in adults with chronic diarrhea undergoing workup for IBD, measured by one specific immunoassay. They are illustrative orientation, not universal targets. Your lab will likely report different numbers and may use different units, so compare your results within the same lab over time for the most meaningful trend.
| Tier | Approximate Range | What It Suggests |
|---|---|---|
| Below threshold | Under 1,357 ng/mL | Active inflammatory bowel disease is less likely, though not excluded |
| Above threshold | 1,357 ng/mL or higher | Pattern consistent with active eosinophil-driven or inflammatory bowel disease; warrants further workup |
Source: Lyutakov et al., Journal of Crohn's and Colitis, 2019.
Eosinophil activity in the gut is not constant. It changes with active flares, dietary exposures, parasite burden, and treatment response. A single reading is a snapshot. What matters more is the direction of change when you modify something, whether that is starting a biologic, removing a food, or treating an infection.
A sensible cadence is to get a baseline when symptoms are present, retest in 4 to 12 weeks after making a change such as an elimination diet or a new prescription, and then at least annually if you are managing a chronic condition like IBD or a known food allergy. If you are healthy and simply curious, a single baseline is a reasonable starting point to revisit if symptoms develop later.
A few factors can distort a single reading. Knowing them helps you interpret an unexpected result before acting on it.
An elevated fecal EPX tells you something is irritating your gut, but not exactly what. The next step depends on the rest of your picture. If you have ongoing diarrhea, blood in your stool, weight loss, or a family history of IBD, pair the result with fecal calprotectin and consider referral to a gastroenterologist for endoscopic evaluation. If you have known food allergies, atopic disease, or eczema, pair it with a careful food and symptom diary and consider an allergist-supervised elimination approach. If you recently traveled or have exposure risk, add a stool parasite panel.
If your result is normal but you still have symptoms, do not stop there. A normal fecal EPX does not rule out everything, and other stool and blood markers can still fill in the picture.
Evidence-backed interventions that affect your EPX level
Eosinophil Protein X is best interpreted alongside these tests.